iSpecimen Statistics
Total Valuation
iSpecimen has a market cap or net worth of $2.40 million. The enterprise value is -$2,735.
| Market Cap | 2.40M |
| Enterprise Value | -2,735 |
Important Dates
The last earnings date was Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
iSpecimen has 9.98 million shares outstanding. The number of shares has increased by 1.69% in one year.
| Shares Outstanding | 9.98M |
| Shares Change (YoY) | +1.69% |
| Shares Change (QoQ) | +0.62% |
| Owned by Insiders (%) | 30.75% |
| Owned by Institutions (%) | 3.00% |
| Float | 7.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.26 |
| Forward PS | 0.27 |
| PB Ratio | 0.35 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.93, with a Debt / Equity ratio of 0.02.
| Current Ratio | 0.93 |
| Quick Ratio | 0.87 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -682.35 |
Financial Efficiency
Return on equity (ROE) is -105.30% and return on invested capital (ROIC) is -166.82%.
| Return on Equity (ROE) | -105.30% |
| Return on Assets (ROA) | -74.40% |
| Return on Capital (ROIC) | -166.82% |
| Revenue Per Employee | $174,868 |
| Profits Per Employee | -$218,298 |
| Employee Count | 53 |
| Asset Turnover | 0.60 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.26% in the last 52 weeks. The beta is 1.69, so iSpecimen's price volatility has been higher than the market average.
| Beta (1Y) | 1.69 |
| 52-Week Price Change | -83.26% |
| 50-Day Moving Average | 0.28 |
| 200-Day Moving Average | 0.54 |
| Relative Strength Index (RSI) | 45.41 |
| Average Volume (30 Days) | 1,024,406 |
Short Selling Information
The latest short interest is 169,163, so 1.70% of the outstanding shares have been sold short.
| Short Interest | 169,163 |
| Short Previous Month | 70,870 |
| Short % of Shares Out | 1.70% |
| Short % of Float | 2.23% |
| Short Ratio (days to cover) | 0.08 |
Income Statement
In the last 12 months, iSpecimen had revenue of $9.27 million and -$11.57 million in losses. Loss per share was -$1.28.
| Revenue | 9.27M |
| Gross Profit | 4.59M |
| Operating Income | -11.63M |
| Pretax Income | -11.57M |
| Net Income | -11.57M |
| EBITDA | -9.41M |
| EBIT | -11.55M |
| Loss Per Share | -$1.28 |
Balance Sheet
The company has $2.56 million in cash and $156,703 in debt, giving a net cash position of $2.40 million or $0.24 per share.
| Cash & Cash Equivalents | 2.56M |
| Total Debt | 156,703 |
| Net Cash | 2.40M |
| Net Cash Per Share | $0.24 |
| Equity / Book Value | 6.81M |
| Book Value Per Share | 0.68 |
| Working Capital | -414,722 |
Cash Flow
In the last 12 months, operating cash flow was -$5.05 million and capital expenditures -$3.48 million, giving a free cash flow of -$8.54 million.
| Operating Cash Flow | -5.05M |
| Capital Expenditures | -3.48M |
| Free Cash Flow | -8.54M |
| FCF Per Share | -$0.94 |
Margins
Gross margin is 49.58%, with operating and profit margins of -125.46% and -124.84%.
| Gross Margin | 49.58% |
| Operating Margin | -125.46% |
| Pretax Margin | -124.84% |
| Profit Margin | -124.84% |
| EBITDA Margin | -101.54% |
| EBIT Margin | -124.65% |
| FCF Margin | -92.10% |
Dividends & Yields
iSpecimen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.69% |
| Shareholder Yield | -1.69% |
| Earnings Yield | -482.69% |
| FCF Yield | -356.12% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
iSpecimen has an Altman Z-Score of -9.06 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.06 |
| Piotroski F-Score | 2 |